Article ID Journal Published Year Pages File Type
5702763 Urologic Oncology: Seminars and Original Investigations 2017 8 Pages PDF
Abstract
The loss of α-secretase activity observed here in conjunction with previous findings argue against tumorigenic effects of ADAM9, 10, and 17 supporting that increased nuclear and cytoplasmic expression may be an attempt to compensate for loss of function.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Changes in expressions of ADAM9, 10, and 17 as well as α-secretase activity in renal cell carcinoma
Authors
, , , , , ,